This paper comprises an updated version of the 2014 review which reported 1846 volatile
organic compounds (VOCs) identified from healthy humans. In total over 900 additional …

Volatile organic compounds (VOCs), produced and emitted through the metabolism of
cancer cells or the body's immune system, are considered novel cancer biomarkers for …

Background Effective screening for colorectal cancer can reduce mortality by early detection
of tumours and colonic polyps. An altered pattern of volatile organic compounds (VOCs) in …

Simple Summary The lack of highly specific and sensitive biomarkers for the early detection
of prostate cancer (PCa) is a major barrier to its management. Volatilomics emerged as a …

The analysis of urinary volatile organic compounds (VOCs) is a promising field of research
with the potential to discover new biomarkers for cancer early detection. This systematic …

METHODS: We compared the exhaled breath of 40 controls, 32 cirrhotic patients, and 12
cirrhotic patients with HCC using the Breath Biopsy platform. Breath samples were analyzed …

Volatile organic compounds (VOCs) profile for diagnosis and monitoring therapeutic
response of hepatocellular carcinoma (HCC) has not been well studied. We determined …

Precision oncology aims to tailor clinical decisions specifically to patients with the objective
of improving treatment outcomes. This can be achieved by leveraging omics information for …

Although there are new approaches in both cancer treatment and diagnosis, overall
mortality is a major concern. New technologies have attempted to look at breath volatile …

Early disease detection is often correlated with a reduction in mortality rate and improved
prognosis. Currently, techniques like biopsy and imaging that are used to screen chronic …